PL88932B1 - - Google Patents

Download PDF

Info

Publication number
PL88932B1
PL88932B1 PL15233671A PL15233671A PL88932B1 PL 88932 B1 PL88932 B1 PL 88932B1 PL 15233671 A PL15233671 A PL 15233671A PL 15233671 A PL15233671 A PL 15233671A PL 88932 B1 PL88932 B1 PL 88932B1
Authority
PL
Poland
Prior art keywords
chlorophenyl
benzene
radical
isobutyl
compound
Prior art date
Application number
PL15233671A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to PL15233671A priority Critical patent/PL88932B1/pl
Publication of PL88932B1 publication Critical patent/PL88932B1/pl

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL15233671A 1971-12-21 1971-12-21 PL88932B1 (oth)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL15233671A PL88932B1 (oth) 1971-12-21 1971-12-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL15233671A PL88932B1 (oth) 1971-12-21 1971-12-21

Publications (1)

Publication Number Publication Date
PL88932B1 true PL88932B1 (oth) 1976-10-30

Family

ID=19956712

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15233671A PL88932B1 (oth) 1971-12-21 1971-12-21

Country Status (1)

Country Link
PL (1) PL88932B1 (oth)

Similar Documents

Publication Publication Date Title
CA1190224A (en) Derivatives of 1,2-diamino-cyclobutene-3,4-dione as potent histamine h.sub.2-antagonists
SE435837B (sv) 4-amino-3-kinolinkarboxylsyror och estrar derav med antisekretorisk och anti-ulceros aktivitet
US3801631A (en) 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts
CA2977521C (en) 1-(aryl)-3-(heteroaryl) urea compounds and their use as olig2 inhibitors
DE2362409A1 (de) N,n'-(phenylen)-di-oxamidsaeuren und deren derivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
DE2509457A1 (de) Oxaminderivate, ein verfahren zu ihrer herstellung sowie arzneimittel
GB1561345A (en) 8 - azapuring - 6 - ones
WO1993024459A1 (en) Quaternary pyridinium compounds
JPH0260671B2 (oth)
PL88932B1 (oth)
WO1995021822A1 (en) Pyridinium compounds
US3546234A (en) Benzene-sulfonyl-semicarbazides
GB1587128A (en) Benzothiazepine derivatives
EP0105458B1 (en) Alpha-aryl-alpha-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
ES2207325T3 (es) ((aminoiminomethil) amino) alcanocarboxamidas y sus aplicaciones terapeuticas.
EP0069154A1 (en) Novel thiazole compounds, process for their preparation, and medicinal composition containing same
SE452007B (sv) Amidinosubstituerade ureaforeningar och en farmaceutisk komposition for behandling av gastrointestinala eller kardiovaskulera rubbningar
JPH02502534A (ja) １‐メチル‐β‐オキソ‐α‐（フェニルカルバモイル）‐２‐ピロールプロピオニトリルのトロメタミン塩
IL38451A (en) Antiviral ureidophenyl-guanidine compounds
PL91733B1 (oth)
US2192828A (en) Therapeutic agent
NO117362B (oth)
PL91055B1 (oth)
PL141942B1 (en) Process for preparing novel,basic oxime ethers
DE2525250A1 (de) Oxaminsaeurederivate, verfahren zu deren herstellung sowie arzneimittel